This study revealed an association between the high probability of death after a stroke or new ischemic episodes and the CD4+CD28 null lymphocyte cell count, and proposed that the number of these lymphocytes could serve as a warning biomarker against recurrence of an ischemic event or death. The gene discussed is CD28; the disease is Stroke.